Armin Nowack is SVP Business Development of Swissfinity Group, a European investment company in the advanced biotech sector.

Armin is a highly accomplished medical device expert with over 30 years of experience in the development, production, regulatory compliance, and marketing of innovative medical devices for healthcare and pharmaceutical manufacturing.

In recent years, he has focused on the rapidly growing field of cell and gene therapy. Over nearly 31 years at Barkey GmbH & Co. KG, including a decade as CEO, he led the company’s strategic growth, operational excellence, and international expansion, playing a key role in its success in cell and gene therapy and its acquisition by a NASDAQ-listed life sciences corporation.

Armin is a collaborative leader who uses his expertise to support organizations in advancing cell and gene therapy products to improve patient care. His leadership emphasizes strategy, innovation, sustainability, and social responsibility while fostering long-term societal impact.